Country: Ġordan
Lingwa: Ingliż
Sors: JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)
Losartan Potassium 100 mg
مستودع أدوية أداتكو - Adatco Drug Store
C09CA01
Losartan Potassium 100 mg
100 mg
30
MSD(MERCK-SHARP&DOHME)LTD/UK (بريطانيا)
6.2 :سعر الجمهور + الضريبة
Profile: BG180x520_260 Profile Revision: 5 Profile Revision Date: 110808 Dimensions (mm): 180 x 520 MSD ARTWORK 401361036-0020 N/A N/A N/A N/A N/A Black Profile Technical Info Package leaflet: Information for the user COZAAR ® 100mg film-coated tablets Losartan potassium Read all of this leaflet carefully before you start taking this medicine because it contains important information for you. • Keep this leaflet. You may need to read it again. • If you have any further questions, ask your doctor, pharmacist, or nurse. • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. • If you get any side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in this leaflet. See section 4. What is in this leaflet 1. What COZAAR is and what it is used for 2. What you need to know before you take COZAAR 3. How to take COZAAR 4. Possible side effects 5. How to store COZAAR 6. Contents of the pack and other information 1. What COZAAR is and what it is used for Losartan (COZAAR) belongs to a group of medicines known as angiotensin-II receptor antagonists. Angiotensin-II is a substance produced in the body which binds to receptors in blood vessels, causing them to tighten. This results in an increase in blood pressure. Losartan prevents the binding of angiotensin-II to these receptors, causing the blood vessels to relax which in turn lowers the blood pressure. Losartan slows the decrease of kidney function in patients with high blood pressure and type 2 diabetes. COZAAR is used • to treat patients with high blood pressure (hypertension) in adults and in children and adolescents 6 – 18 years of age. • to protect the kidney in hypertensive type 2 diabetic patients with laboratory evidence of impaired renal function and proteinuria ≥ 0.5 g per day (a condition in which urine contains an abnormal amount of protein). • to treat patients with chronic heart failure when therap Aqra d-dokument sħiħ